Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,895,910
+$1,925,974 QoQ
Shares Held
41,869
+88.9% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
2.72%
of 13F equity value
Holder Rank
#88
of 282 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 42%
Shared 0%
None 58%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $69,797,747 across 47 Biotechnology names. BNTX ranks #3 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $11,925,150 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
41,987 | $3,995,902 | |
| 3 | BNTX |
BioNTech SE
This page
|
41,869 | $3,895,910 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
78,310 | $3,683,702 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
110,870 | $3,418,122 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
220,180 | $3,208,022 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
79,043 | $2,745,953 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,432 | $2,698,237 |
All Filings in BNTX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,895,910 | 41,869 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,969,936 | 22,164 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,639,153 | 17,218 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $1,741,629 | 17,660 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,720,555 | 16,160 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,563,955 | 17,175 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,159,352 | 18,950 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,562,419 | 13,155 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,191,015 | 27,265 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $325,181 | 3,525 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $393,136 | 3,725 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $374,264 | 3,445 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $359,298 | 3,329 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $336,339 | 2,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $405,594 | 2,700 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $364,176 | 2,700 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $328,020 | 2,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $446,867 | 2,620 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $761,799 | 2,955 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $300,289 | 1,100 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||